Check Before You Invest : Vivo Bio Tech Ltd

Snapshot

Q.1 Which industry/sub-sector does Vivo Bio Tech Ltd belong to?

Vivo Bio Tech Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Vivo Bio Tech Ltd a good quality company?

Vivo Bio Tech Ltd is a quality company, based on a 10-year financial track record.

Q.3 Is Vivo Bio Tech Ltd undervalued or overvalued?

Vivo Bio Tech Ltd appears Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Vivo Bio Tech Ltd a good buy now?

Vivo Bio Tech Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd revenue growth is 4% for FY-2025, which is above its 5-year CAGR of -3.35%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Return on capital employed is 13.06% for FY-2025, which is above its 5-year historical median of 11.26%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Return on Asset is 5.48%, which is above its 5-year historical median of 2.23%, indicating improved asset utilization efficiency.

Q.4 Return on Equity (ROE) of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Return on equity is 12.13% for FY-2025, which is above its 5-year historical median of 5.41%, indicating the business is making better use of its shareholders capital.

Q.5 Cash conversion cycle of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Cash conversion cycle is 140 days, above its 5-year historical median of 131 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.34	0.43
ROE	12.13	5.41
ROCE	13.06	11.26
Cash Conversion Cycle	140 days	131 days

Q.6 Gross Profit margin of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Gross profit margin which is the profit after deduction of direct costs, is 38.8% for FY-2025, which is above its 5-year median of 27.5%, indicating increasing margins.

Q.7 Operating Profit Margin of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 44.66% for FY-2025, which is above its 5-year median of 42.27% indicating increasing margins.

Q.8 Net Profit Margin of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Net Profit Margin is 16.22% for FY-2025, is above with its 5-year median of 5.62%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	38.8	27.5
Operating Profit Margin	44.66	42.27
Net Profit Margin	16.22	5.62

Q.9 Debt to Equity ratio of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Debt-to-Equity ratio is 0.73, which is above with the industry average of 0.27, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd Debt to cash flow from operations is 4.38, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Vivo Bio Tech Ltd?

Promoters hold 35.43% of the Vivo Bio Tech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Vivo Bio Tech Ltd vs industry peers?

Vivo Bio Tech Ltd revenue CAGR is -3.35%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	4	8.3
Gross Profit Growth	35.6	14.7
Operating Profit Growth	-1.9	11.4
Net Profit Growth	200.4	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.34	0.81
ROE	12.13	9.49
ROCE	13.06	11.91
Cash Conversion Cycle (days)	140.41	85

Valuation & price assessment

Q.1 Stock return of Vivo Bio Tech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -3.8% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-3.8%	-14.7%	3.7%	-25.3%

Q.3 Valuation ratios of Vivo Bio Tech Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	13.2	18.51	31.09
Price to Book	0.64	1.02	2.85
Price to Sales	1.21	1.27	2.79
EV to EBITDA	4.85	5.25	15.87

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Force Motors Ltd.

2. KEI Industries Ltd.

3. Aadhar Housing Finance Ltd.

4. State Bank Of India

5. Power Finance Corporation Ltd.